Theravance Inc news

   Watch this stock
Showing stories 1 - 6 of about 6   

Articles published

THRX 15.00 -0.32 (-2.09%)
price chart
Theravance licenses antibiotic tech to Hospira
(Reuters) - Biopharmaceutical company Theravance Inc said it licensed its technology to manufacture antibiotic Vibativ to specialty medicines maker Hospira Inc. The company would purchase from Hospira more than a majority of its Vibativ 750 mg dosage ...
Related articles »  
GlaxoSmithKline boosts Theravance stake
Following approval Tuesday by Theravance stockholders, GSK's previously announced acquisition of 10 million shares of Theravance is now complete - meaning GSK owns 25.8 million shares of Theravance common stock. That's 26.7 percent of the total ...
Related articles »  
Obama, Romney 'shake the trees' in California
Dennis Driver of Sacramento, a vice president of the Bay Area biopharmaceutical company Theravance Inc., increased his donation to Obama to $2,500 this year, up from $500 in 2008.
Related articles »  
Tracking Seth Klarman's Baupost Group Holdings: Q1 2012 Update
Theravance Inc (NASDAQ:THRX): THRX, approximately 10% of the US long portfolio position, was increased marginally this quarter.
Related articles »  
Elevation boasts "gold standard" IIb data for COPD therapy
Four months ago San Diego-based Elevation Pharmaceuticals unveiled a $30 million venture round as it mapped out plans to complete an ambitious mid-stage program for its COPD treatment.
Related articles »  
Seth Klarman Betting Big On These 2 Stocks
Shares in Theravance Inc. (NASDAQ:THRX) increasing 42%; Shares in NovaGold (NYSEMKT:NG) Increasing 49%; Shares in PDL BioPharma (NASDAQ:PDLI) decreasing 49%; Shares in Idenix Pharma (NASDAQ:IDIX) increasing 127%.
Related articles »